MedTrace Logo

Evolution of Clinical and Motivational Constructs During the Physical Activity Program KHEOPS, Already Offered to Patients at the Centre Léon Bérard

NCT07515326 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2026-04-07

No results posted yet for this study

Summary

CANDY is a single-center, prospective study designed to observe the evolution of clinical and motivational constructs during the APA program KHEOPS program, already offered to patients at the Centre Léon Bérard (CLB).

The main aim of the CANDY study is to observe the evolution of psychological constructs derived from M-PAC during a 13-week KHEOPS APA program in women undergoing treatment for breast cancer.

Secondary objectives are:

* to examine the feasibility of psychological measures and participation in the KHEOPS program
* to observe cancer-related psychological symptoms during the KHEOPS program and to investigate the links between the temporal evolution of psychological factors (clinical and motivational) and adherence to the KHEOPS program, as well as the level of post-program PA during and after the KHEOPS program in patients followed at the CLB.

Conditions

Interventions

BEHAVIORAL

KHEOPS program

the KHEOPS program is an physical activity intervention, offered to patients

Sponsors & Collaborators

  • Cancéropôle Lyon Auvergne Rhône-Alpes

    collaborator OTHER

  • Centre Leon Berard

    lead OTHER

Principal Investigators

  • Olivia Perol, PhD · Département Prévention Cancer Environnement, Centre Léon Bérard

  • Béatrice Fervers, Pr · Département Prévention Cancer Environnement, Centre Léon Bérard

  • Johan Caudroit, PhD · Université Lyon1

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-18
Primary Completion
2026-09-30
Completion
2026-09-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07515326 on ClinicalTrials.gov